- 1. Patients exhibiting symptoms judged related to prostate cancer by the investigator (e.g., bone pain, pelvic pain, ureteral obstruction) who urgently require hormone therapy such as GnRH agonist, GnRH antagonist, or CAB/MAB therapy, chemotherapy, or radiotherapy.